The global Necrotizing Ulcerative Gingivitis (NUG) Treatment market size is expected to reach US$ 10530 million by 2029, growing at a CAGR of 7.5% from 2023 to 2029.

Necrotizing Ulcerative Gingivitis (NUG) Treatment - Market

Treatment of ANUG is by removal of dead gum tissue and antibiotics (usually metronidazole) in the acute phase, and improving oral hygiene to prevent recurrence. Although the condition has a rapid onset and is debilitating, it usually resolves quickly and does no serious harm.

The market is mainly driven by the significant applications of Necrotizing Ulcerative Gingivitis (NUG) Treatment in various end use industries. The expanding demands from the Hospitals, Homecare, Pharmacies and Others, are propelling Necrotizing Ulcerative Gingivitis (NUG) Treatment market. Medication, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Surgery segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Necrotizing Ulcerative Gingivitis (NUG) Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Necrotizing Ulcerative Gingivitis (NUG) Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Necrotizing Ulcerative Gingivitis (NUG) Treatment sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Necrotizing Ulcerative Gingivitis (NUG) Treatment covered in this report include Novartis, Teva Pharmaceutical, Mylan, Sanofi, GlaxoSmithKline, Merck, Otsuka Pharmaceutical, Abbott Laboratories and Eli Lilly and Company, etc.

The global Necrotizing Ulcerative Gingivitis (NUG) Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Novartis

Teva Pharmaceutical

Mylan

Sanofi

GlaxoSmithKline

Merck

Otsuka Pharmaceutical

Abbott Laboratories

Eli Lilly and Company

Hindustan Antibiotics

Scope of Necrotizing Ulcerative Gingivitis (NUG) Treatment - Market Report

Report Metric	Details
Report Name	Necrotizing Ulcerative Gingivitis (NUG) Treatment - Market
Forecasted market size in 2029	US$ 10530 million
CAGR	7.5%
Forecasted years	2024 - 2029
Global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, Segment by Type:	Medication Surgery
Global Necrotizing Ulcerative Gingivitis (NUG) Treatment market, by Application	Hospitals Homecare Pharmacies Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Necrotizing Ulcerative Gingivitis (NUG) Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Necrotizing Ulcerative Gingivitis (NUG) Treatment - Market size in 2029?

Ans: The Necrotizing Ulcerative Gingivitis (NUG) Treatment - Market size in 2029 will be US$ 10530 million.

What are the Application segmentation covered in the Necrotizing Ulcerative Gingivitis (NUG) Treatment - Market report?

Ans: The Applications covered in the Necrotizing Ulcerative Gingivitis (NUG) Treatment - Market report are Hospitals, Homecare, Pharmacies, Others

What are the Type segmentation covered in the Necrotizing Ulcerative Gingivitis (NUG) Treatment - Market report?

Ans: The Types covered in the Necrotizing Ulcerative Gingivitis (NUG) Treatment - Market report are Medication, Surgery

1 Market Overview of Necrotizing Ulcerative Gingivitis (NUG) Treatment

1.1 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Overview

1.1.1 Necrotizing Ulcerative Gingivitis (NUG) Treatment Product Scope

1.1.2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Status and Outlook

1.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2018-2029)

1.4 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Region (2018-2023)

1.5 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)

1.6.1 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)

1.6.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)

1.6.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)

1.6.4 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)

1.6.5 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029)

2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market by Type

2.1 Introduction

2.1.1 Medication

2.1.2 Surgery

2.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Type (2018-2023)

2.2.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Type (2018-2029)

3 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Overview by Application

3.1 Introduction

3.1.1 Hospitals

3.1.2 Homecare

3.1.3 Pharmacies

3.1.4 Others

3.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Historic Market Size by Application (2018-2023)

3.2.2 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Breakdown by Application (2018-2029)

4 Necrotizing Ulcerative Gingivitis (NUG) Treatment Competition Analysis by Players

4.1 Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment as of 2022)

4.3 Date of Key Players Enter into Necrotizing Ulcerative Gingivitis (NUG) Treatment Market

4.4 Global Top Players Necrotizing Ulcerative Gingivitis (NUG) Treatment Headquarters and Area Served

4.5 Key Players Necrotizing Ulcerative Gingivitis (NUG) Treatment Product Solution and Service

4.6 Competitive Status

4.6.1 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Novartis

5.1.1 Novartis Profile

5.1.2 Novartis Main Business

5.1.3 Novartis Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

5.1.4 Novartis Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)

5.1.5 Novartis Recent Developments

5.2 Teva Pharmaceutical

5.2.1 Teva Pharmaceutical Profile

5.2.2 Teva Pharmaceutical Main Business

5.2.3 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

5.2.4 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)

5.2.5 Teva Pharmaceutical Recent Developments

5.3 Mylan

5.3.1 Mylan Profile

5.3.2 Mylan Main Business

5.3.3 Mylan Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

5.3.4 Mylan Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)

5.3.5 Sanofi Recent Developments

5.4 Sanofi

5.4.1 Sanofi Profile

5.4.2 Sanofi Main Business

5.4.3 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

5.4.4 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)

5.4.5 Sanofi Recent Developments

5.5 GlaxoSmithKline

5.5.1 GlaxoSmithKline Profile

5.5.2 GlaxoSmithKline Main Business

5.5.3 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

5.5.4 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)

5.5.5 GlaxoSmithKline Recent Developments

5.6 Merck

5.6.1 Merck Profile

5.6.2 Merck Main Business

5.6.3 Merck Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

5.6.4 Merck Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)

5.6.5 Merck Recent Developments

5.7 Otsuka Pharmaceutical

5.7.1 Otsuka Pharmaceutical Profile

5.7.2 Otsuka Pharmaceutical Main Business

5.7.3 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

5.7.4 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)

5.7.5 Otsuka Pharmaceutical Recent Developments

5.8 Abbott Laboratories

5.8.1 Abbott Laboratories Profile

5.8.2 Abbott Laboratories Main Business

5.8.3 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

5.8.4 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)

5.8.5 Abbott Laboratories Recent Developments

5.9 Eli Lilly and Company

5.9.1 Eli Lilly and Company Profile

5.9.2 Eli Lilly and Company Main Business

5.9.3 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

5.9.4 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)

5.9.5 Eli Lilly and Company Recent Developments

5.10 Hindustan Antibiotics

5.10.1 Hindustan Antibiotics Profile

5.10.2 Hindustan Antibiotics Main Business

5.10.3 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

5.10.4 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) & (2018-2023)

5.10.5 Hindustan Antibiotics Recent Developments

6 North America

6.1 North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2029)

6.2 United States

6.3 Canada

7 Europe

7.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Dynamics

11.1 Necrotizing Ulcerative Gingivitis (NUG) Treatment Industry Trends

11.2 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Drivers

11.3 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Challenges

11.4 Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Otsuka Pharmaceutical

Abbott Laboratories

Eli Lilly and Company

Hindustan Antibiotics

List of Tables

Table 1. Global Market Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Share by Region (2018-2023)

Table 4. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2018-2023)

Table 9. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2024-2029)

Table 11. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2018-2023)

Table 24. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2024-2029)

Table 26. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Necrotizing Ulcerative Gingivitis (NUG) Treatment as of 2022)

Table 39. Date of Key Players Enter into Necrotizing Ulcerative Gingivitis (NUG) Treatment Market

Table 40. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Key Players Headquarters and Area Served

Table 41. Necrotizing Ulcerative Gingivitis (NUG) Treatment Product Solution and Service

Table 42. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Novartis Basic Information List

Table 45. Novartis Description and Business Overview

Table 46. Novartis Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

Table 47. Revenue (US$ Million) in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business of Novartis (2018-2023)

Table 48. Novartis Recent Developments

Table 49. Teva Pharmaceutical Basic Information List

Table 50. Teva Pharmaceutical Description and Business Overview

Table 51. Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

Table 52. Revenue (US$ Million) in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business of Teva Pharmaceutical (2018-2023)

Table 53. Teva Pharmaceutical Recent Developments

Table 54. Mylan Basic Information List

Table 55. Mylan Description and Business Overview

Table 56. Mylan Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

Table 57. Revenue (US$ Million) in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business of Mylan (2018-2023)

Table 58. Mylan Recent Developments

Table 59. Sanofi Basic Information List

Table 60. Sanofi Description and Business Overview

Table 61. Sanofi Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

Table 62. Revenue (US$ Million) in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business of Sanofi (2018-2023)

Table 63. Sanofi Recent Developments

Table 64. GlaxoSmithKline Basic Information List

Table 65. GlaxoSmithKline Description and Business Overview

Table 66. GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

Table 67. Revenue (US$ Million) in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business of GlaxoSmithKline (2018-2023)

Table 68. GlaxoSmithKline Recent Developments

Table 69. Merck Basic Information List

Table 70. Merck Description and Business Overview

Table 71. Merck Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

Table 72. Revenue (US$ Million) in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business of Merck (2018-2023)

Table 73. Merck Recent Developments

Table 74. Otsuka Pharmaceutical Basic Information List

Table 75. Otsuka Pharmaceutical Description and Business Overview

Table 76. Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

Table 77. Revenue (US$ Million) in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business of Otsuka Pharmaceutical (2018-2023)

Table 78. Otsuka Pharmaceutical Recent Developments

Table 79. Abbott Laboratories Basic Information List

Table 80. Abbott Laboratories Description and Business Overview

Table 81. Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

Table 82. Revenue (US$ Million) in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business of Abbott Laboratories (2018-2023)

Table 83. Abbott Laboratories Recent Developments

Table 84. Eli Lilly and Company Basic Information List

Table 85. Eli Lilly and Company Description and Business Overview

Table 86. Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

Table 87. Revenue (US$ Million) in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business of Eli Lilly and Company (2018-2023)

Table 88. Eli Lilly and Company Recent Developments

Table 89. Hindustan Antibiotics Basic Information List

Table 90. Hindustan Antibiotics Description and Business Overview

Table 91. Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Treatment Products, Services and Solutions

Table 92. Revenue (US$ Million) in Necrotizing Ulcerative Gingivitis (NUG) Treatment Business of Hindustan Antibiotics (2018-2023)

Table 93. Hindustan Antibiotics Recent Developments

Table 94. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 95. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 96. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 97. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 98. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 99. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2018-2023) & (US$ Million)

Table 100. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Region (2024-2029) & (US$ Million)

Table 101. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region (2018-2023)

Table 102. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region (2024-2029)

Table 103. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 104. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 105. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 106. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 107. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 108. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 109. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Trends

Table 110. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Drivers

Table 111. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Challenges

Table 112. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Regions: 2022 VS 2029

Figure 4. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Medication

Figure 11. Global Medication Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Surgery

Figure 13. Global Surgery Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Share by Type: 2022 & 2029

Figure 15. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2018-2029)

Figure 16. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2018-2029)

Figure 17. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2018-2029)

Figure 18. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2018-2029)

Figure 19. Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Type (2018-2029)

Figure 20. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 21. Homecare Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 22. Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 23. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 24. Global Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size Share by Application: 2022 & 2029

Figure 25. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2018-2029)

Figure 26. Europe Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2018-2029)

Figure 27. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2018-2029)

Figure 28. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2018-2029)

Figure 29. Middle East and Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Revenue Market Share by Application (2018-2029)

Figure 30. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 31. Global Top 5 and Top 10 Players Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share in 2022

Figure 32. North America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2018-2029)

Figure 33. United States Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 34. Canada Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 35. Germany Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 36. France Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 37. U.K. Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 38. Italy Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 39. Russia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 40. Nordic Countries Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 41. Asia-Pacific Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Region (2018-2029)

Figure 42. China Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 43. Japan Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 44. South Korea Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 45. Southeast Asia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 46. India Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 47. Australia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 48. Latin America Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2018-2029)

Figure 49. Mexico Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 50. Brazil Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 51. Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Share by Country (2018-2029)

Figure 52. Turkey Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 53. Saudi Arabia Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 54. UAE Necrotizing Ulcerative Gingivitis (NUG) Treatment Market Size (2018-2029) & (US$ Million)

Figure 55. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Allergy Eye Drop Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39W12362

Tue Jul 30 00:00:00 UTC 2024

Add to Cart

Global IgA Nephropathy Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-30S12876

Mon Jul 29 00:00:00 UTC 2024

Add to Cart

Global Drug for Organ Rejection Prophylaxis Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29F12983

Mon Jul 29 00:00:00 UTC 2024

Add to Cart

Global Primary Immunodeficiency Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10Q15349

Mon Jul 29 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions